Institutional investors purchased a net $606.3 thousand shares of ICCC during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 22.45% of the shares outstanding that institutional investors hold is among the lowest in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORTHPOINTE CAPITAL LLC Bought 255.3 Thousand shares of ImmuCell Corp
HEARTLAND ADVISORS, INC. Bought 203.1 Thousand shares of ImmuCell Corp
PERRITT CAPITAL MANAGEMENT, INC. Bought 82.6 Thousand shares of ImmuCell Corp